Related references
Note: Only part of the references are listed.HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy
C. Nelson Hayes et al.
GUT (2011)
Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors
Masayuki Kurosaki et al.
JOURNAL OF HEPATOLOGY (2011)
Analysis of Interferon Signaling by Infectious Hepatitis C Virus Clones with Substitutions of Core Amino Acids 70 and 91
Yusuke Funaoka et al.
JOURNAL OF VIROLOGY (2011)
The role of triple therapy in HCV genotype 1-experienced patients
Michael W. Fried
LIVER INTERNATIONAL (2011)
Amino Acid Substitution in Hepatitis C Virus Core Region and Genetic Variation Near the Interleukin 28B Gene Predict Viral Response to Telaprevir with Peginterferon and Ribavirin
Norio Akuta et al.
HEPATOLOGY (2010)
HCV Genetic Elements Determining the Early Response to Peginterferon and Ribavirin Therapy
Nobuyuki Enomoto et al.
INTERVIROLOGY (2010)
Contribution of Genome-Wide HCV Genetic Differences to Outcome of Interferon-Based Therapy in Caucasian American and African American Patients
Maureen J. Donlin et al.
PLOS ONE (2010)
The global burden of hepatitis C
Daniel Lavanchy
LIVER INTERNATIONAL (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy
Ahmed El-Shamy et al.
HEPATOLOGY (2008)
Interaction of hepatitis c virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles
Takahiro Masaki et al.
JOURNAL OF VIROLOGY (2008)
Regulation of hepatitis C virion production via phosphorylation of the NS5A protein
Timothy L. Tellinghuisen et al.
PLOS PATHOGENS (2008)
Amino acid substitutions in the hepatitis c virus core region are the important predictor of hepatocarcinogenesis
Norio Akuta et al.
HEPATOLOGY (2007)
Impact of Asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C
Sharif Missiha et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
The lipid droplet is an important organelle for hepatitis C virus production
Yusuke Miyanari et al.
NATURE CELL BIOLOGY (2007)
Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy
Maureen J. Donlin et al.
JOURNAL OF VIROLOGY (2007)
Phosphorylation of hepatitis C virus NS5A nonstructural protein: A new paradigm for phosphorylation-dependent viral RNA replication?
Ying Huang et al.
VIROLOGY (2007)
Replication of hepatitis C virus
Darius Moradpour et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replication
T. Kohashi et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1
MJ Walsh et al.
GUT (2006)
Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy
K Hamano et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA
JK Pfeiffer et al.
JOURNAL OF VIROLOGY (2005)
Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy
N Akuta et al.
INTERVIROLOGY (2005)
Hepatitis C virus NS5A: tales of a promiscuous protein
A Macdonald et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells
S Maekawa et al.
JOURNAL OF VIRAL HEPATITIS (2004)
Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy
KC Young et al.
HEPATOLOGY (2003)
Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-α and ribavirin therapy in chronic hepatitis C infection
MD Murphy et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
Efficient initiation of HCV RNA replication in cell culture
KJ Blight et al.
SCIENCE (2000)
Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response
C Sarrazin et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
